A polymorphism at the 3'-UTR region of the aromatase gene is associated with the efficacy of the aromatase inhibitor, anastrozole, in metastatic breast carcinoma

31Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Estrogen-related genes and the fat mass and obesity-associated (FTO) gene play a critical role in estrogen metabolism, and those polymorphisms are associated with a poor prognosis in breast cancer. However, little is known about the association between these polymorphisms and the efficacy of anastrozole. The aim was to investigate the impact of the genetic polymorphisms, CYP19A1, 17-β-HSD-1 and FTO, on the response to anastrozole in metastatic breast carcinoma (MBC) and to evaluate the impact of those polymorphisms on various clinicopathologic features. Two-hundred seventy-two women with hormone receptor-positive MBC treated with anastrozole were identified retrospectively. DNA was extracted from peripheral blood and genotyped for five variants in three candidate genes. Time to progression was improved in patients carrying the variant alleles of rs4646 when compared to patients with the wild-type allele (16.40 months versus 13.52 months; p = 0.049). The rs4646 variant alleles were significantly associated with longer overall survival (37.3 months versus 31.6 months; p = 0.007). This relationship was not observed with the rs10046, rs2830, rs9926298 and rs9939609 polymorphisms. The findings of this study indicate that rs4646 polymorphism in the CYP19A1 gene may serve as a prognostic maker of the response to anastrozole in patients with MBC who are treated with anastrozole. © 2013 by the authors; licensee MDPI, Basel, Switzerland.

Figures

  • Table 1. Patients’ characteristics.
  • Table 1. Cont.
  • Table 2. Characteristics of five SNPs in the three genes analyzed.
  • Table 2. Cont.
  • Table 3. Correlations of rs4646 and clinical variables.
  • Table 4. Correlation between response to treatment and adverse effects segregated with respect to SNP rs4646.
  • Figure 1. Time to progression segregated on the absence or presence of the rs4646 SNP variant (n = 262; normal: GG; variant: GT or TT). Log-rank, p = 0.049.
  • Figure 2. Overall survival segregated on the absence or presence of the rs4646 SNP variant (n = 262; normal: GG; variant: GT or TT). Log-rank, p = 0.007.

References Powered by Scopus

Cancer treatment and survivorship statistics, 2012

2541Citations
N/AReaders
Get full text

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

0
2143Citations
N/AReaders
Get full text

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial

1927Citations
N/AReaders
Get full text

Cited by Powered by Scopus

High efficiency silicon nanowire/organic hybrid solar cells with two-step surface treatment

42Citations
N/AReaders
Get full text

Alternative splicing in the cytochrome P450 superfamily expands protein diversity to augment gene function and redirect human drug metabolism

40Citations
N/AReaders
Get full text

Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: A systematic review and meta-analysis

35Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Liu, L., Bai, Y. X., Zhou, J. H., Sun, X. W., Sui, H., Zhang, W. J., … Zhang, Q. Y. (2013). A polymorphism at the 3’-UTR region of the aromatase gene is associated with the efficacy of the aromatase inhibitor, anastrozole, in metastatic breast carcinoma. International Journal of Molecular Sciences, 14(9), 18973–18988. https://doi.org/10.3390/ijms140918973

Readers over time

‘14‘15‘16‘17‘18‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

50%

Researcher 7

39%

Professor / Associate Prof. 2

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

37%

Agricultural and Biological Sciences 5

26%

Biochemistry, Genetics and Molecular Bi... 5

26%

Pharmacology, Toxicology and Pharmaceut... 2

11%

Save time finding and organizing research with Mendeley

Sign up for free
0